ArticleDrug design, development and therapy2026

Drug-Drug Interaction of Chiglitazar with Empagliflozin, Atorvastatin, and Valsartan: An Open-Label, Single-Center, Self-Control, 3-Period Study.

Lei Sheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.